US military announces detention of Islamic State leader
US Central Command (Centcom) wrote on X that the operations, conducted from May 21 to 27, 'served to disrupt and degrade' IS's ability to 'reconstitute, plan, organise and conduct attacks against civilians and US and partner forces in the region'.
In the course of supporting six operations in the ongoing campaign, five in Iraq and one in Syria, the US military reported two IS operatives were killed, two were detained – including an IS leader – and multiple weapons were recovered.
'Operations like these underscore the commitment of Centcom, along with our allies and partners, to the enduring defeat of ISIS in the region,' Centcom Commander Michael Erik Kurilla said in a statement.
The operations in Iraq were carried out by Iraqi forces in the north, where IS cells have remained active and carry out sporadic attacks against Iraq's army and police.
IS in 2014 declared a 'caliphate' after capturing large parts of Iraq and Syria, beginning a rule marked by atrocities.
Iraqi forces backed by the international coalition defeated IS in late 2017. The group lost its last territory in Syria two years later.
The group has, however, maintained a presence in Syria's north-east where it notably targets Kurdish-led forces, and in Iraq it largely carries out attacks in rural areas.
About 2,500 American troops are deployed in Iraq, which now considers its security forces capable of confronting the jihadists.
The US and Iraq announced in late September 2024 that the international coalition would end its decade-long military mission in federal Iraq within a year, and by September 2026 in the autonomous Kurdistan region.
During his recent Gulf tour, US President Donald Trump met with Syria's interim President Ahmed al-Sharaa in Saudi Arabia and announced lifting sanctions on Syria. AFP
Join ST's Telegram channel and get the latest breaking news delivered to you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
International Business Times
an hour ago
- International Business Times
Appeals Court Questions Trump's Use of Emergency Powers to Justify Tariffs
A US federal appeals court raised serious doubts about President Donald Trump's authority to impose broad tariffs under emergency powers. During a hearing in Washington, D.C., judges questioned whether the International Emergency Economic Powers Act (IEEPA) grants the president the legal right to impose tariffs on allied nations like Canada, China, and Mexico. Trump had used IEEPA to introduce what he called "reciprocal" tariffs in April and further increased them in February. The case now before the U.S. Court of Appeals for the Federal Circuit was brought by five small businesses and 12 Democratic-led states. They argue that Trump overstepped his powers and that only Congress has the constitutional right to set tariffs and taxes. Government lawyer Brett Shumate defended Trump's move, saying IEEPA gives the president broad authority in economic emergencies, including regulating imports. But Judge Jimmie Reyna responded, "IEEPA doesn't even mention tariffs." Several judges appeared skeptical throughout the 90-minute hearing, which concluded without a ruling date. The outcome of this case could have major implications. Trump, who made tariffs a key trade tool during his second term, claims they helped address unfair trade practices and boosted U.S. manufacturing. He cited the U.S. trade deficit and illegal fentanyl imports as justification. However, critics argue these reasons do not constitute an "extraordinary threat" under the law. Earlier this year, a lower court also ruled that IEEPA does not support tariffs based on long-term trade imbalances. The appeals court has allowed the tariffs to stay in place while legal challenges continue. With customs duties now generating over $100 billion in revenue this fiscal year, tariffs have become a significant funding source. Still, economists warn that they raise consumer prices and disrupt supply chains. The Trump administration argues that removing tariff power could harm trade negotiations, although recent deals with the EU, Japan, and others have moved forward. Trump has warned of further tariff hikes on countries not reaching new trade deals by August 1. The final decision in this case is likely to head to the U.S. Supreme Court if either side loses.
International Business Times
an hour ago
- International Business Times
Trump Demands Drug Price Cuts in Letters to 17 Pharma Giants Summary
US President Donald Trump has sent letters to 17 major pharmaceutical companies demanding they cut prescription drug prices in the United States. The letters, released Thursday by the White House, outline his plan to match U.S. prices with those in other developed countries. President Donald Trump addessses the nation after U.S. bombed Iran's nuclear facilities X Trump recently signed an executive order requiring drugmakers to offer "most-favored-nation" pricing. This means companies must sell medications to U.S. patients at the lowest price they offer elsewhere. If drug companies do not comply, Trump warned the government could import cheaper alternatives or take other steps. Companies that received the letters include Pfizer, Eli Lilly, Johnson & Johnson, Merck, Sanofi, and AstraZeneca. Trump had previously criticized earlier proposals from the industry, saying they prioritized profits over patient care. He also demanded that drugmakers return any excess profits made by raising prices overseas to compensate American taxpayers. Shares of major pharmaceutical firms fell after the announcement. Pfizer, Eli Lilly, and Gilead each dropped by around 2%, while a broader index of drug stocks declined 3%. Trump also suggested a system where companies can sell drugs directly to patients, bypassing middlemen, but only if they agree to international pricing rules. The president gave drugmakers a deadline of September 29 to respond with binding commitments. Health experts are skeptical that companies will meet Trump's demands. Some analysts believe the proposals are unlikely to result in immediate price changes, describing them as more political pressure than enforceable policy. Still, several companies, including Pfizer and Novartis, said they are open to working with the administration. Pfizer confirmed its ongoing talks with Trump officials to improve access and affordability for U.S. patients. U.S. drug prices remain among the highest in the world, with patients often paying nearly three times more than those in other developed countries. Drugmakers argue that sharp price cuts could harm innovation, but Trump insists bold action is needed to protect Americans from high costs.
Straits Times
an hour ago
- Straits Times
Trump eyes bringing Azerbaijan, Central Asian nations into Abraham Accords, sources say
Sign up now: Get ST's newsletters delivered to your inbox FILE PHOTO: U.S. President Donald Trump delivers remarks in the Roosevelt Room at the White House in Washington, D.C., U.S., July 31, 2025. REUTERS/Kent Nishimura/File Photo WASHINGTON - President Donald Trump's administration is actively discussing with Azerbaijan the possibility of bringing that nation and some Central Asian allies into the Abraham Accords, hoping to deepen their existing ties with Israel, according to five sources with knowledge of the matter. As part of the Abraham Accords, inked in 2020 and 2021 during Trump's first term in office, four Muslim-majority countries agreed to normalize diplomatic relations with Israel after U.S. mediation. Azerbaijan and every country in Central Asia, by contrast, already have longstanding relations with Israel, meaning that an expansion of the accords to include them would largely be symbolic, focusing on strengthening ties in areas like trade and military cooperation, said the sources, who requested anonymity to discuss private conversations. Such an expansion would reflect Trump's openness to pacts that are less ambitious than his administration's goal to convince regional heavyweight Saudi Arabia to restore ties with Israel while war rages in Gaza. The kingdom has repeatedly said it would not recognize Israel without steps towards Israeli recognition of a Palestinian state. A soaring death toll in Gaza and starvation in the enclave due to blockage of aid and military operations by Israel have buoyed Arab fury, complicating efforts to add more Muslim-majority countries to the Abraham Accords. The war in Gaza, where over 60,000 people including tens of thousands of women and children have died according to local health authorities, has provoked global anger. Canada, France and the United Kingdom have announced plans in recent days to recognize an independent Palestine. Another key sticking point is Azerbaijan's conflict with its neighbor Armenia, since the Trump administration considers a peace deal between the two Caucasus nations as a precondition to join the Abraham Accords, three sources said. Top stories Swipe. Select. Stay informed. Tech Reporting suspected advanced cyber attacks will provide a defence framework: Shanmugam Business Singapore's US tariff rate stays at 10%, but the Republic is not out of the woods yet Asia Asia-Pacific economies welcome new US tariff rates, but concerns over extent of full impact remain Business ST explains: How Trump tariffs could affect Singapore SMEs, jobs and markets Asia Indonesia's Mount Lewotobi Laki-laki erupts Singapore Thundery showers expected on most days in first half of August Singapore Synapxe chief executive, MND deputy secretary to become new perm secs on Sept 1 Singapore 5 women face capital charges after they were allegedly found with nearly 27kg of cocaine in S'pore While Trump officials have publicly floated several potential entrants into the accords, the talks centered on Azerbaijan are among the most structured and serious, the sources said. Two of the sources argued a deal could be reached within months or even weeks. Trump's special envoy for peace missions, Steve Witkoff, traveled to Azerbaijan's capital, Baku, in March to meet with Azerbaijani President Ilham Aliyev. Aryeh Lightstone, a key Witkoff aide, met Aliyev later in the spring in part to discuss the Abraham Accords, three of the sources said. As part of the discussions, Azerbaijani officials have contacted officials in Central Asian nations, including in nearby Kazakhstan, to gauge their interest in a broader Abraham Accords expansion, those sources said. It was not clear which other countries in Central Asia - which includes Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan and Kyrgyzstan - were contacted. The State Department, asked for comment, did not discuss specific countries, but said expanding the accords has been one of the key objectives of Trump. "We are working to get more countries to join," said a U.S. official. The Azerbaijani government declined to comment. The White House, the Israeli foreign ministry and the Kazakhstani embassy in Washington did not respond to requests for comment. Any new accords would not modify the previous Abraham Accords deals signed by Israel. OBSTACLES REMAIN The original Abraham Accords - inked between Israel and the United Arab Emirates, Bahrain, Morocco and Sudan - were centered on restoration of ties. The second round of expansion appears to be morphing into a broader mechanism designed to expand U.S. and Israeli soft power. Wedged between Russia to the north and Iran to the south, Azerbaijan occupies a critical link in trade flows between Central Asia and the West. The Caucasus and Central Asia are also rich in natural resources, including oil and gas, prompting various major powers to compete for influence in the region. Expanding the accords to nations that already have diplomatic relations with Israel may also be a means of delivering symbolic wins to a president who is known to talk up even relatively small victories. Two sources described the discussions involving Central Asia as embryonic - but the discussions with Azerbaijan as relatively advanced. But challenges remain and there is no guarantee a deal will be reached, particularly with slow progress in talks between Armenia and Azerbaijan. The two countries, which both won independence from the Soviet Union in 1991, have been at loggerheads since the late 1980s when Nagorno-Karabakh - an Azerbaijani region that had a mostly ethnic-Armenian population - broke away from Azerbaijan with support from Armenia. In 2023, Azerbaijan retook Karabakh, prompting about 100,000 ethnic Armenians to flee to Armenia. Both sides have since said they want to sign a treaty on a formal end to the conflict. Primarily Christian Armenia and the U.S. have close ties, and the Trump administration is wary of taking action that could upset authorities in Yerevan. Still, U.S. officials, including Secretary of State Marco Rubio and Trump himself, have argued that a peace deal between those two nations is near. "Armenia and Azerbaijan, we worked magic there," Trump told reporters earlier in July. "And it's pretty close." REUTERS
